This inventor holds 2 USPTO granted patents. Top assignee: The University of Hong Kong. Active years: 2013-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2017
Title: Lok Fung Chow: Innovator in Cancer Treatment
Introduction
Lok Fung Chow is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of pharmaceutical sciences, particularly in cancer treatment. With a total of 2 patents, his work focuses on innovative compositions that aim to combat cancer effectively.
Latest Patents
One of Lok Fung Chow's latest patents is a pharmaceutical composition containing cyclometalated N-heterocyclic carbene complexes for cancer treatment. This composition includes a cyclometalated N-heterocyclic carbene complex that contains either a gold(III) or a platinum(II) atom. The pharmaceutical composition demonstrates anti-cancer activity, which includes the induction of cell death, inhibition of cellular proliferation, and the inhibition and poisoning of topoisomerase.
Career Highlights
Lok Fung Chow is affiliated with The University of Hong Kong, where he conducts research and develops innovative solutions in the pharmaceutical field. His work has garnered attention for its potential impact on cancer therapies.
Collaborations
Some of his notable coworkers include Chi Ming Che and Raymond Wai-Yin Sun, who contribute to the collaborative efforts in research and development within the university.
Conclusion
Lok Fung Chow's innovative work in cancer treatment through his patented pharmaceutical compositions highlights his commitment to advancing medical science. His contributions are paving the way for new therapeutic options in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile